1
3
2
75.3, 172.6, 136.7, 130.9, 130.2, 127.2, 126.3, 52.3, 52.1, 42.1,
General procedure for the rhodium-catalysed conjugate addition of
organotrialkoxysilanes to a-amino acrylates
+
+
5.6, 35.4, 19.6; HRMS (EI ) [MH ]; calcd for C14
H
18
O
4
, m/z
51.1278; found m/z 251.1282.
A suspension of ethyl-a-phthalimidoacrylate (0.5 mmol), organo-
trialkoxysilane (1.25 mmol), and [Rh(cod)
2
][BF ] (0.015 mmol, 3
4
Dimethyl 2-(4-methoxybenzyl)succinate (7e). Title compound
isolated as a colourless oil (116 mg, 87%); R (9 : 1, petroleum
mol%), in dioxane (2 mL) and water (0.2 mL) was refluxed under
an inert atmosphere. After 24 hours the solution was evaporated
under reduced pressure and re-dissolved in ethyl acetate (10 mL)
and water (10 mL). The phases were separated, and the aqueous
phase extracted with ethyl acetate (2 × 10 mL). The combined
f
−
1
1
ether–ethyl acetate) 0.18; IR (film, cm ) m 2953, 1732 (C=O); H
NMR (300 MHz, CDCl
) d 7.0 (2H, d, J = 8.7 Hz, Ar), 6.76 (2H,
d, J = 8.7 Hz, Ar), 3.72 (3H, s, ArOCH ), 3.60 (3H, s, CH ),
.57 (3H, s, CH ), 2.8–3.1 (2H, m, CH , CH), 2.5–2.7 (2H, m,
CH ). Further data were in
), 2.33 (1H, dd, J = 5.1, 16.8 Hz, CH
accordance with previous results in the literature.
3
3
3
3
3
2
organics were washed with brine, dried over MgSO , filtered
4
2
2
21
and concentrated in vacuo. The crude material was purified by
flash chromatography on silica gel (eluent: petroleum ether–ethyl
acetate).
Dimethyl 2-((phenanthren-10-yl)methyl)succinate (7f). Title
◦
compound isolated as a white solid (150 mg, 89%), mp 94–97 C;
−
1
R
2
(
f
(9 : 1, petroleum ether–ethyl acetate) 0.15; IR (CDCl
3
1
, cm ) m
Ethyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoate(9a). Title
923, 2726, 2671, 1719, 1460, 1377, 1305, 1151, 1076; H NMR
300 MHz, CDCl
) d 8.7–8.6 (1H, m, Ar), 8.55 (1H, d, J = 8.0 Hz,
Ar), 8.1–8.2 (1H, m, Ar), 7.75 (1H, dd, J = 1.3, 7.4 Hz, Ar),
.7–7.4 (5H, m, Ar), 3.65 (3H, s, CH ), 3.5–3.6 (1H, m, CH ), 3.5
3H, s, CH ), 3.25–3.4 (1H, m, CH), 3.1–3.2 (1H, m, CH ), 2.7
), 2.4 (1H, dd, J = 4.5, 11.9 Hz,
); C NMR (75.5 MHz; CDCl ) 175.3, 172.6, 132.8, 131.8,
compound isolated as a white solid (126 mg, 78%); R
f
(4 : 1,
1
petroleum ether–ethyl acetate) 0.42; H NMR (300 MHz, CDCl )
3
3
d 7.74–7.79 (2H, m, Ar), 7.66–7.70 (2H, m, Ar), 7.12–7.20 (5H, m,
Ph), 5.14 (1H, dd, J = 5.3, 10.9, NCH), 4.25 (2H, dq, J = 1.6,
7
(
3
2
7.2, CH
2
CH
3
), 3.49–3.64 (2H, m, CH
2
Ph), 1.26 (3H, t, J = 7.2,
3
2
(
1H, dd, J = 9.8, 7.8 Hz, CH
2
CH
3
). Further data were in accordance with previous results in
1
3
18
CH
2
3
the literature.
1
31.2, 131.1, 130.4, 128.6, 128.4, 127.3, 127.1, 126.8, 124.6, 123.7,
+
+
Ethyl 3-(naphthalen-1-yl)-2-(1,3-dioxoisoindolin-2-yl) propanoate
9b). Title compound isolated as a white solid (168 mg, 90%);
1
C
22.8, 52.4, 52.1, 42.0, 36.1, 35.6; HRMS (EI ) [MH ]; calcd for
, m/z 337.1434, found 337.1438.
(
21
H
20
O
4
◦
mp 233–234 C; R
f
(4 : 1, petroleum ether–ethyl acetate) 0.38; mp
◦
1
Dimethyl 2-allylsuccinate (7g). Title compound isolated as a
colourless oil (46 mg, 49%); R (9 : 1, petroleum ether–ethyl acetate)
.19; H NMR (300 MHz, CDCl ) d 5.6–5.7 (1H, m, CH), 5.05
),
), 3.0–2.9 (1H, m, CH), 2.65 (1H, dd, J = 9.08,
), 2.34 (2H, m, CH ), 2.2 (1H, m, CH). Further data
87–90 C; H NMR (300 MHz, CDCl
3
) d 8.10 (1H, d, J = 8.7,
Ar), 7.81 (1H, d, J = 8.7 Hz, Ar), 7.72–7.76 (2H, m, Ar), 7.65–7.69
(3H, m, Ar), 7.43–7.51 (2H, m, Ar), 7.22–7.26 (2H, m, Ar), 5.31
(1H, dd, J = 4.5, 11.3 Hz), 4.3 (2H, dq, J = 1.1, 7.2), 4.17 (1H,
dd, J = 4.5, 14.7 Hz), 3.9 (1H, dd, J = 11.3, 14.7), 1.28 (3H, t, J =
f
1
0
3
(
3
1H, d, J = 4.29 Hz, CH), 4.95 (1H, s, CH), 3.60 (3H, s, CH
3
.58 (3H, s, CH
.63 Hz, CH
3
1
3
7
2
2
7.2 Hz); C NMR (75.5 MHz, CDCl ) 167.7, 166.2, 132.8, 132.6,
3
21
were in accordance with previous results in the literature.
131.7, 130.5, 130.3, 127.7, 126.6, 126.0, 125.2, 124.5, 124.0, 122.2,
1
21.8, 60.9, 51.6, 30.6, 12.9. Further data were in accordance with
18
Dimethyl 2-(4-(trifluoromethyl)benzyl)succinate (7h). Title
compound isolated as a colourless oil (140 mg, 92%); R (4 :
previous results in the literature.
f
−
1
1
, petroleum ether–ethyl acetate) 0.37; IR (film, cm ) m 2955,
Ethyl 3-(4-butylphenyl)-2-(1,3-dioxoisoindolin-2-yl) propanoate
1
2259, 1925, 1732, 1619, 1585, 1548, 1438, 1418, 1324; H NMR
(9c). Title compound isolated as a colourless oil (120 mg, 63%);
R (4 : 1, petroleum ether–ethyl acetate) 0.41; IR (film, cm ) m 2930,
−
1
(300 MHz, CDCl
3
) d 7.47 (2H, d, J = 8.2 Hz, Ar), 7.2 (2H, d, J =
.9 Hz, Ar), 3.58 (3H, s, CH ), 3.57 (3H, s, CH ), 3.05–3.11 (2H,
, CH), 2.78 (1H, dd, J = 7.15, 13.1 Hz, CH ), 2.6 (1H, dd,
J = 8.2, 16.5 Hz, CH ), 2.34 (1H, dd, J = 5.2, 16.5 Hz, CH
NMR (75.5 MHz, CDCl ) 173.1, 170.9, 141.4, 127.8, 124.9, 121.3,
17.7, 50.9, 50.8, 41.7, 36.3, 33.9; HRMS (EI ) [MNH
·NH m/z 322.1261, found 322.1260.
f
1
7
3
3
1778, 1744 (C=O), 1719, 1614, 1515, 1467, 1445, 1388, 1243; H
NMR (300 MHz, CDCl
) d 7.6–7.7 (4H, m, Ar), 6.98 (2H, d, J =
8.08 Hz, Ar), 6.9 (2H, d, J = 8.08 Hz, Ar), 5.06 (1H, dd, J = 5.6,
10.89, NCH), 4.16 (2H, dq, J = 1.7, 7.1 Hz, CH CH ), 3.38–3.54
(2H, m, CHCH ), 1.35–1.45 (2H,
), 2.41 (2H, t, J = 7.56 Hz, CH
m, CH ), 1.1–1.2 (5H, m, CH CH
), 0.8 (3H, t, J = 7.27, CH
NMR (75.5 MHz, CDCl ) 169.3, 167.9, 141.7, 134.5, 134.4, 134.2,
32.0, 129.0, 128.9, 123.7, 62.3, 53.9, 35.5, 34.6, 33.8, 22.6, 14.5,
m, CH
2
2
3
1
3
2
2
);
C
3
2
3
+
+
1
4
]; calcd
2
2
1
3
for C14
H
15
O
4
F
3
4
2
3
2
3
); C
3
Dimethyl 2-(4-(biphenyl)benzyl)succinate (7i). Title compound
1
1
◦
isolated as a white solid (93 mg, 60%); mp 61–65 C; R
f
(4 : 1,
+
+
4.3; HRMS (EI ) [MH ]; calcd for C23
H
25NO , m/z 380.1856,
4
−
1
petroleum ether–ethyl acetate) 0.3; IR (KBr, cm ) m 3027 (C–H),
found 380.1856.
3
1
005 (C–H), 2954 (C–H), 2926 (C–H), 1761 (C=O), 1726 (C=O),
1
175 (C–O), 1153 (C–O); H NMR (300 MHz, CDCl
3
) d 7.42–7.50
Ethyl 2-(1,3-dioxoisoindolin-2-yl)-3-o-tolylpropanoate (9d). Title
compound isolated as a colourless oil (116 mg, 69%); R (4 : 1,
petroleum ether–ethyl acetate) 0.35; IR (film, cm ) m 2981, 1777,
(
7
(
2
4
1
4
4H, m, Ar), 7.3–7.38 (2H, m, Ar), 7.2–7.28 (1H, m, Ar), 7.14–
.16 (2H, m, Ar), 3.6 (3H, s, CH ), 3.56 (3H, s, CH ), 2.98–3.12
2H, m, CH ),
, CH), 2.68–2.76 (1H, dd, J = 8.2, 13.1 Hz, CH
.58–2.67 (1H, dd, J = 8.6, 16.1 Hz, CH ), 2.32–2.4 (1H, dd, J =
.8, 16.5 Hz, CH ); C NMR (75.5 MHz, CDCl ) 175.1, 172.7,
41.1, 140.0, 137.6, 129.8, 129.2, 127.6, 127.4, 127.0, 52.5, 52.4,
f
−
1
3
3
1
2
2
1743, 1715, 1631, 1494, 1467, 1423, 1388; H NMR (300 MHz,
2
CDCl
(4H, m, Ph), 5.09 (1H, dd, J = 5.3, 10.9, NCH), 4.1 (2H, dq, J =
1.9, 7.2, CH CH ), 3.4–3.64 (2H, m, CH Ph), 2.3 (3H, s, Ar–Me),
), C NMR (75.5 MHz, CDCl ) 169.4,
3
) d 7.74–7.79 (2H, m, Ar), 7.66–7.70 (2H, m, Ar), 6.9–7.1
1
3
2
3
2
3
2
+
+
13
3.4, 37.7, 35.3; HRMS (EI ) [MNH
4
]; calcd for C19
H
20
O
4
·NH
4
1.26 (3H, t, J = 7.2, CH
3
3
m/z 330.1700, found 330.1700.
167.9, 136.9, 135.2, 134.5, 131.9, 130.9, 130.0, 127.4, 126.3, 123.8,
This journal is © The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 3235–3241 | 3239